Elevated levels of pro-calcific and pro-apoptotic EV-associated miR-145-5p contribute to the progression of CAVD via the ZEB2-ALPL axis, which could potentially be therapeutically targeted to minimize the burden of CAVD. The gene discussed is ALPL; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.